nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP2A6—stomach cancer	0.218	0.507	CbGaD
Amiodarone—ADRB1—stomach cancer	0.212	0.493	CbGaD
Amiodarone—ABCB1—Mitomycin—stomach cancer	0.0432	0.148	CbGbCtD
Amiodarone—CYP2A6—Fluorouracil—stomach cancer	0.0319	0.109	CbGbCtD
Amiodarone—CYP3A7—Irinotecan—stomach cancer	0.0227	0.0776	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0227	0.0776	CbGbCtD
Amiodarone—CYP2C9—Capecitabine—stomach cancer	0.0185	0.0632	CbGbCtD
Amiodarone—CYP3A5—Irinotecan—stomach cancer	0.017	0.0582	CbGbCtD
Amiodarone—CYP3A7—Docetaxel—stomach cancer	0.0166	0.0569	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0166	0.0569	CbGbCtD
Amiodarone—CYP2C8—Fluorouracil—stomach cancer	0.0157	0.0537	CbGbCtD
Amiodarone—CYP3A5—Docetaxel—stomach cancer	0.0125	0.0427	CbGbCtD
Amiodarone—CYP1A2—Fluorouracil—stomach cancer	0.0122	0.0416	CbGbCtD
Amiodarone—ABCB1—Irinotecan—stomach cancer	0.0111	0.0379	CbGbCtD
Amiodarone—CYP2C9—Fluorouracil—stomach cancer	0.011	0.0375	CbGbCtD
Amiodarone—ABCB1—Docetaxel—stomach cancer	0.00813	0.0278	CbGbCtD
Amiodarone—CYP3A4—Irinotecan—stomach cancer	0.00664	0.0227	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—stomach cancer	0.00606	0.0207	CbGbCtD
Amiodarone—ABCB1—Methotrexate—stomach cancer	0.00587	0.02	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—stomach cancer	0.00571	0.0195	CbGbCtD
Amiodarone—Lucanthone—APEX1—stomach cancer	0.005	0.903	CrCbGaD
Amiodarone—CYP3A4—Docetaxel—stomach cancer	0.00487	0.0166	CbGbCtD
Amiodarone—CYP3A4—Doxorubicin—stomach cancer	0.00363	0.0124	CbGbCtD
Amiodarone—EBP—endocrine gland—stomach cancer	0.00134	0.0478	CbGeAlD
Amiodarone—EBP—liver—stomach cancer	0.00121	0.0431	CbGeAlD
Amiodarone—CACNA1H—smooth muscle tissue—stomach cancer	0.000974	0.0347	CbGeAlD
Amiodarone—THRB—endocrine gland—stomach cancer	0.000792	0.0282	CbGeAlD
Amiodarone—THRA—endocrine gland—stomach cancer	0.000792	0.0282	CbGeAlD
Amiodarone—CACNA2D2—endocrine gland—stomach cancer	0.000784	0.0279	CbGeAlD
Amiodarone—THRB—liver—stomach cancer	0.000714	0.0254	CbGeAlD
Amiodarone—THRA—liver—stomach cancer	0.000714	0.0254	CbGeAlD
Amiodarone—CYP3A7—endocrine gland—stomach cancer	0.000677	0.0241	CbGeAlD
Amiodarone—CACNA1H—endocrine gland—stomach cancer	0.000636	0.0226	CbGeAlD
Amiodarone—CYP3A7—liver—stomach cancer	0.00061	0.0217	CbGeAlD
Amiodarone—CACNA1H—liver—stomach cancer	0.000573	0.0204	CbGeAlD
Amiodarone—SIGMAR1—smooth muscle tissue—stomach cancer	0.000556	0.0198	CbGeAlD
Amiodarone—THRB—lymph node—stomach cancer	0.000547	0.0195	CbGeAlD
Amiodarone—THRA—lymph node—stomach cancer	0.000547	0.0195	CbGeAlD
Amiodarone—CACNA2D2—lymph node—stomach cancer	0.000542	0.0193	CbGeAlD
Amiodarone—CYP2C19—hematopoietic system—stomach cancer	0.000526	0.0187	CbGeAlD
Amiodarone—CYP3A7-CYP3A51P—liver—stomach cancer	0.000519	0.0185	CbGeAlD
Amiodarone—SIGMAR1—pancreas—stomach cancer	0.000514	0.0183	CbGeAlD
Amiodarone—KCNH2—hematopoietic system—stomach cancer	0.000502	0.0179	CbGeAlD
Amiodarone—CYP2C8—hematopoietic system—stomach cancer	0.000459	0.0164	CbGeAlD
Amiodarone—CACNA1H—lymph node—stomach cancer	0.000439	0.0156	CbGeAlD
Amiodarone—CYP1A2—hematopoietic system—stomach cancer	0.00043	0.0153	CbGeAlD
Amiodarone—CYP1A1—hematopoietic system—stomach cancer	0.000424	0.0151	CbGeAlD
Amiodarone—CYP2A6—liver—stomach cancer	0.000424	0.0151	CbGeAlD
Amiodarone—CYP3A5—hematopoietic system—stomach cancer	0.000415	0.0148	CbGeAlD
Amiodarone—ABCB1—blood vessel—stomach cancer	0.000414	0.0147	CbGeAlD
Amiodarone—CYP2C9—hematopoietic system—stomach cancer	0.000408	0.0145	CbGeAlD
Amiodarone—SIGMAR1—bone marrow—stomach cancer	0.000404	0.0144	CbGeAlD
Amiodarone—CYP1A1—epithelium—stomach cancer	0.000388	0.0138	CbGeAlD
Amiodarone—Dronedarone—ADRB1—stomach cancer	0.000386	0.0697	CrCbGaD
Amiodarone—ADRB1—endocrine gland—stomach cancer	0.000378	0.0135	CbGeAlD
Amiodarone—CYP2C19—digestive system—stomach cancer	0.000366	0.013	CbGeAlD
Amiodarone—CYP3A5—pancreas—stomach cancer	0.000338	0.012	CbGeAlD
Amiodarone—SIGMAR1—liver—stomach cancer	0.000327	0.0116	CbGeAlD
Amiodarone—KCNH2—bone marrow—stomach cancer	0.000322	0.0115	CbGeAlD
Amiodarone—CYP3A4—hematopoietic system—stomach cancer	0.000311	0.0111	CbGeAlD
Amiodarone—CYP2D6—hematopoietic system—stomach cancer	0.000306	0.0109	CbGeAlD
Amiodarone—CYP2C19—endocrine gland—stomach cancer	0.000302	0.0108	CbGeAlD
Amiodarone—CYP1A2—digestive system—stomach cancer	0.000299	0.0106	CbGeAlD
Amiodarone—CYP1A1—digestive system—stomach cancer	0.000295	0.0105	CbGeAlD
Amiodarone—KCNH2—endocrine gland—stomach cancer	0.000289	0.0103	CbGeAlD
Amiodarone—CYP3A5—digestive system—stomach cancer	0.000288	0.0103	CbGeAlD
Amiodarone—CYP2C9—digestive system—stomach cancer	0.000284	0.0101	CbGeAlD
Amiodarone—CYP2C19—liver—stomach cancer	0.000273	0.00971	CbGeAlD
Amiodarone—CYP2C8—endocrine gland—stomach cancer	0.000264	0.0094	CbGeAlD
Amiodarone—SIGMAR1—lymph node—stomach cancer	0.000251	0.00892	CbGeAlD
Amiodarone—CYP1A2—endocrine gland—stomach cancer	0.000247	0.00879	CbGeAlD
Amiodarone—CYP1A1—endocrine gland—stomach cancer	0.000244	0.00868	CbGeAlD
Amiodarone—CYP3A5—endocrine gland—stomach cancer	0.000238	0.00848	CbGeAlD
Amiodarone—CYP2C8—liver—stomach cancer	0.000238	0.00847	CbGeAlD
Amiodarone—CYP2C9—endocrine gland—stomach cancer	0.000235	0.00835	CbGeAlD
Amiodarone—CYP1A2—liver—stomach cancer	0.000223	0.00793	CbGeAlD
Amiodarone—ABCB1—hematopoietic system—stomach cancer	0.00022	0.00784	CbGeAlD
Amiodarone—CYP1A1—liver—stomach cancer	0.00022	0.00782	CbGeAlD
Amiodarone—CYP3A4—digestive system—stomach cancer	0.000216	0.0077	CbGeAlD
Amiodarone—CYP3A5—liver—stomach cancer	0.000215	0.00765	CbGeAlD
Amiodarone—CYP2D6—digestive system—stomach cancer	0.000213	0.00758	CbGeAlD
Amiodarone—CYP2C9—liver—stomach cancer	0.000211	0.00753	CbGeAlD
Amiodarone—ABCB1—epithelium—stomach cancer	0.000201	0.00717	CbGeAlD
Amiodarone—KCNH2—lymph node—stomach cancer	0.000199	0.0071	CbGeAlD
Amiodarone—ABCB1—pancreas—stomach cancer	0.000179	0.00639	CbGeAlD
Amiodarone—CYP3A4—endocrine gland—stomach cancer	0.000179	0.00637	CbGeAlD
Amiodarone—CYP2D6—endocrine gland—stomach cancer	0.000176	0.00626	CbGeAlD
Amiodarone—CYP1A1—lymph node—stomach cancer	0.000168	0.006	CbGeAlD
Amiodarone—CYP3A4—liver—stomach cancer	0.000161	0.00574	CbGeAlD
Amiodarone—CYP2D6—liver—stomach cancer	0.000159	0.00565	CbGeAlD
Amiodarone—Dronedarone—ALB—stomach cancer	0.000155	0.028	CrCbGaD
Amiodarone—ABCB1—lymphoid tissue—stomach cancer	0.000155	0.00552	CbGeAlD
Amiodarone—ABCB1—digestive system—stomach cancer	0.000153	0.00545	CbGeAlD
Amiodarone—ABCB1—bone marrow—stomach cancer	0.000141	0.00503	CbGeAlD
Amiodarone—ABCB1—endocrine gland—stomach cancer	0.000127	0.00451	CbGeAlD
Amiodarone—ABCB1—liver—stomach cancer	0.000114	0.00406	CbGeAlD
Amiodarone—Confusional state—Docetaxel—stomach cancer	8.76e-05	0.000549	CcSEcCtD
Amiodarone—ABCB1—lymph node—stomach cancer	8.75e-05	0.00312	CbGeAlD
Amiodarone—Anxiety—Capecitabine—stomach cancer	8.74e-05	0.000548	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—stomach cancer	8.7e-05	0.000545	CcSEcCtD
Amiodarone—Anaphylactic shock—Docetaxel—stomach cancer	8.68e-05	0.000544	CcSEcCtD
Amiodarone—Oedema—Docetaxel—stomach cancer	8.68e-05	0.000544	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—stomach cancer	8.67e-05	0.000543	CcSEcCtD
Amiodarone—Discomfort—Capecitabine—stomach cancer	8.67e-05	0.000543	CcSEcCtD
Amiodarone—Infection—Docetaxel—stomach cancer	8.63e-05	0.000541	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—stomach cancer	8.62e-05	0.00054	CcSEcCtD
Amiodarone—Diarrhoea—Irinotecan—stomach cancer	8.6e-05	0.000539	CcSEcCtD
Amiodarone—Dry mouth—Capecitabine—stomach cancer	8.58e-05	0.000537	CcSEcCtD
Amiodarone—Agranulocytosis—Epirubicin—stomach cancer	8.57e-05	0.000537	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—stomach cancer	8.55e-05	0.000536	CcSEcCtD
Amiodarone—Shock—Docetaxel—stomach cancer	8.54e-05	0.000535	CcSEcCtD
Amiodarone—Pruritus—Fluorouracil—stomach cancer	8.51e-05	0.000533	CcSEcCtD
Amiodarone—Thrombocytopenia—Docetaxel—stomach cancer	8.5e-05	0.000533	CcSEcCtD
Amiodarone—Visual impairment—Methotrexate—stomach cancer	8.49e-05	0.000532	CcSEcCtD
Amiodarone—Confusional state—Capecitabine—stomach cancer	8.48e-05	0.000531	CcSEcCtD
Amiodarone—Tachycardia—Docetaxel—stomach cancer	8.48e-05	0.000531	CcSEcCtD
Amiodarone—Skin disorder—Docetaxel—stomach cancer	8.43e-05	0.000529	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	8.42e-05	0.000528	CcSEcCtD
Amiodarone—Oedema—Capecitabine—stomach cancer	8.41e-05	0.000527	CcSEcCtD
Amiodarone—Bradycardia—Epirubicin—stomach cancer	8.39e-05	0.000526	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—stomach cancer	8.35e-05	0.000523	CcSEcCtD
Amiodarone—Infection—Capecitabine—stomach cancer	8.35e-05	0.000523	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—stomach cancer	8.33e-05	0.000522	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—stomach cancer	8.33e-05	0.000522	CcSEcCtD
Amiodarone—Dizziness—Irinotecan—stomach cancer	8.31e-05	0.000521	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—stomach cancer	8.28e-05	0.000519	CcSEcCtD
Amiodarone—Anorexia—Docetaxel—stomach cancer	8.28e-05	0.000519	CcSEcCtD
Amiodarone—Shock—Capecitabine—stomach cancer	8.27e-05	0.000518	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—stomach cancer	8.24e-05	0.000517	CcSEcCtD
Amiodarone—Diarrhoea—Fluorouracil—stomach cancer	8.23e-05	0.000516	CcSEcCtD
Amiodarone—Thrombocytopenia—Capecitabine—stomach cancer	8.23e-05	0.000516	CcSEcCtD
Amiodarone—Tinnitus—Methotrexate—stomach cancer	8.21e-05	0.000515	CcSEcCtD
Amiodarone—Tachycardia—Capecitabine—stomach cancer	8.21e-05	0.000514	CcSEcCtD
Amiodarone—Skin disorder—Capecitabine—stomach cancer	8.17e-05	0.000512	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—stomach cancer	8.15e-05	0.00051	CcSEcCtD
Amiodarone—Hyperhidrosis—Capecitabine—stomach cancer	8.13e-05	0.000509	CcSEcCtD
Amiodarone—Hypotension—Docetaxel—stomach cancer	8.11e-05	0.000508	CcSEcCtD
Amiodarone—Anorexia—Capecitabine—stomach cancer	8.01e-05	0.000502	CcSEcCtD
Amiodarone—Vomiting—Irinotecan—stomach cancer	7.99e-05	0.000501	CcSEcCtD
Amiodarone—Dizziness—Fluorouracil—stomach cancer	7.96e-05	0.000499	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—stomach cancer	7.94e-05	0.000498	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—stomach cancer	7.93e-05	0.000497	CcSEcCtD
Amiodarone—Rash—Irinotecan—stomach cancer	7.92e-05	0.000496	CcSEcCtD
Amiodarone—Dermatitis—Irinotecan—stomach cancer	7.91e-05	0.000496	CcSEcCtD
Amiodarone—Headache—Irinotecan—stomach cancer	7.87e-05	0.000493	CcSEcCtD
Amiodarone—Hypotension—Capecitabine—stomach cancer	7.86e-05	0.000492	CcSEcCtD
Amiodarone—Insomnia—Docetaxel—stomach cancer	7.85e-05	0.000492	CcSEcCtD
Amiodarone—Paraesthesia—Docetaxel—stomach cancer	7.8e-05	0.000489	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—stomach cancer	7.79e-05	0.000488	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—stomach cancer	7.78e-05	0.000488	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—stomach cancer	7.77e-05	0.000487	CcSEcCtD
Amiodarone—Dyspnoea—Docetaxel—stomach cancer	7.74e-05	0.000485	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—stomach cancer	7.69e-05	0.000482	CcSEcCtD
Amiodarone—Erythema—Methotrexate—stomach cancer	7.67e-05	0.000481	CcSEcCtD
Amiodarone—Flushing—Epirubicin—stomach cancer	7.65e-05	0.000479	CcSEcCtD
Amiodarone—Vomiting—Fluorouracil—stomach cancer	7.65e-05	0.000479	CcSEcCtD
Amiodarone—Dyspepsia—Docetaxel—stomach cancer	7.64e-05	0.000479	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—stomach cancer	7.63e-05	0.000478	CcSEcCtD
Amiodarone—Insomnia—Capecitabine—stomach cancer	7.6e-05	0.000477	CcSEcCtD
Amiodarone—Rash—Fluorouracil—stomach cancer	7.59e-05	0.000475	CcSEcCtD
Amiodarone—Dermatitis—Fluorouracil—stomach cancer	7.58e-05	0.000475	CcSEcCtD
Amiodarone—Paraesthesia—Capecitabine—stomach cancer	7.55e-05	0.000473	CcSEcCtD
Amiodarone—Decreased appetite—Docetaxel—stomach cancer	7.55e-05	0.000473	CcSEcCtD
Amiodarone—Headache—Fluorouracil—stomach cancer	7.54e-05	0.000472	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—stomach cancer	7.51e-05	0.000471	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Docetaxel—stomach cancer	7.5e-05	0.00047	CcSEcCtD
Amiodarone—Dyspnoea—Capecitabine—stomach cancer	7.5e-05	0.00047	CcSEcCtD
Amiodarone—Fatigue—Docetaxel—stomach cancer	7.49e-05	0.000469	CcSEcCtD
Amiodarone—Nausea—Irinotecan—stomach cancer	7.46e-05	0.000468	CcSEcCtD
Amiodarone—Pain—Docetaxel—stomach cancer	7.43e-05	0.000465	CcSEcCtD
Amiodarone—Constipation—Docetaxel—stomach cancer	7.43e-05	0.000465	CcSEcCtD
Amiodarone—Back pain—Methotrexate—stomach cancer	7.42e-05	0.000465	CcSEcCtD
Amiodarone—Dyspepsia—Capecitabine—stomach cancer	7.4e-05	0.000464	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—stomach cancer	7.36e-05	0.000462	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—stomach cancer	7.35e-05	0.000461	CcSEcCtD
Amiodarone—Decreased appetite—Capecitabine—stomach cancer	7.31e-05	0.000458	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—stomach cancer	7.29e-05	0.000457	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Capecitabine—stomach cancer	7.26e-05	0.000455	CcSEcCtD
Amiodarone—Fatigue—Capecitabine—stomach cancer	7.25e-05	0.000454	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—stomach cancer	7.23e-05	0.000453	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—stomach cancer	7.21e-05	0.000452	CcSEcCtD
Amiodarone—Pain—Capecitabine—stomach cancer	7.19e-05	0.000451	CcSEcCtD
Amiodarone—Constipation—Capecitabine—stomach cancer	7.19e-05	0.000451	CcSEcCtD
Amiodarone—Erythema—Epirubicin—stomach cancer	7.18e-05	0.00045	CcSEcCtD
Amiodarone—Feeling abnormal—Docetaxel—stomach cancer	7.16e-05	0.000448	CcSEcCtD
Amiodarone—Nausea—Fluorouracil—stomach cancer	7.15e-05	0.000448	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—stomach cancer	7.12e-05	0.000446	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—stomach cancer	7.11e-05	0.000446	CcSEcCtD
Amiodarone—Gastrointestinal pain—Docetaxel—stomach cancer	7.1e-05	0.000445	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—stomach cancer	7.08e-05	0.000444	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—stomach cancer	7.03e-05	0.00044	CcSEcCtD
Amiodarone—Back pain—Epirubicin—stomach cancer	6.94e-05	0.000435	CcSEcCtD
Amiodarone—Feeling abnormal—Capecitabine—stomach cancer	6.93e-05	0.000434	CcSEcCtD
Amiodarone—Malaise—Methotrexate—stomach cancer	6.92e-05	0.000433	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—stomach cancer	6.89e-05	0.000432	CcSEcCtD
Amiodarone—Gastrointestinal pain—Capecitabine—stomach cancer	6.88e-05	0.000431	CcSEcCtD
Amiodarone—Body temperature increased—Docetaxel—stomach cancer	6.86e-05	0.00043	CcSEcCtD
Amiodarone—Abdominal pain—Docetaxel—stomach cancer	6.86e-05	0.00043	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—stomach cancer	6.81e-05	0.000427	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—stomach cancer	6.76e-05	0.000424	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—stomach cancer	6.74e-05	0.000422	CcSEcCtD
Amiodarone—Cough—Methotrexate—stomach cancer	6.69e-05	0.000419	CcSEcCtD
Amiodarone—Urticaria—Capecitabine—stomach cancer	6.68e-05	0.000419	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—stomach cancer	6.66e-05	0.000417	CcSEcCtD
Amiodarone—Abdominal pain—Capecitabine—stomach cancer	6.65e-05	0.000416	CcSEcCtD
Amiodarone—Body temperature increased—Capecitabine—stomach cancer	6.65e-05	0.000416	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—stomach cancer	6.64e-05	0.000416	CcSEcCtD
Amiodarone—Agitation—Epirubicin—stomach cancer	6.6e-05	0.000413	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—stomach cancer	6.5e-05	0.000407	CcSEcCtD
Amiodarone—Malaise—Epirubicin—stomach cancer	6.47e-05	0.000406	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—stomach cancer	6.45e-05	0.000404	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—stomach cancer	6.45e-05	0.000404	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—stomach cancer	6.42e-05	0.000403	CcSEcCtD
Amiodarone—Hypersensitivity—Docetaxel—stomach cancer	6.4e-05	0.000401	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—stomach cancer	6.31e-05	0.000395	CcSEcCtD
Amiodarone—Cough—Epirubicin—stomach cancer	6.26e-05	0.000392	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—stomach cancer	6.26e-05	0.000392	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—stomach cancer	6.26e-05	0.000392	CcSEcCtD
Amiodarone—Asthenia—Docetaxel—stomach cancer	6.23e-05	0.00039	CcSEcCtD
Amiodarone—Infection—Methotrexate—stomach cancer	6.22e-05	0.00039	CcSEcCtD
Amiodarone—Hypersensitivity—Capecitabine—stomach cancer	6.19e-05	0.000388	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—stomach cancer	6.16e-05	0.000386	CcSEcCtD
Amiodarone—Pruritus—Docetaxel—stomach cancer	6.14e-05	0.000385	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—stomach cancer	6.13e-05	0.000384	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—stomach cancer	6.1e-05	0.000382	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—stomach cancer	6.09e-05	0.000382	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—stomach cancer	6.08e-05	0.000381	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—stomach cancer	6.05e-05	0.000379	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—stomach cancer	6.04e-05	0.000378	CcSEcCtD
Amiodarone—Asthenia—Capecitabine—stomach cancer	6.03e-05	0.000378	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—stomach cancer	5.99e-05	0.000375	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—stomach cancer	5.98e-05	0.000374	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—stomach cancer	5.97e-05	0.000374	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—stomach cancer	5.97e-05	0.000374	CcSEcCtD
Amiodarone—Pruritus—Capecitabine—stomach cancer	5.95e-05	0.000373	CcSEcCtD
Amiodarone—Diarrhoea—Docetaxel—stomach cancer	5.94e-05	0.000372	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—stomach cancer	5.91e-05	0.00037	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—stomach cancer	5.86e-05	0.000367	CcSEcCtD
Amiodarone—Oedema—Epirubicin—stomach cancer	5.86e-05	0.000367	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—stomach cancer	5.85e-05	0.000366	CcSEcCtD
Amiodarone—Infection—Epirubicin—stomach cancer	5.82e-05	0.000365	CcSEcCtD
Amiodarone—Cough—Doxorubicin—stomach cancer	5.79e-05	0.000363	CcSEcCtD
Amiodarone—Shock—Epirubicin—stomach cancer	5.76e-05	0.000361	CcSEcCtD
Amiodarone—Diarrhoea—Capecitabine—stomach cancer	5.75e-05	0.00036	CcSEcCtD
Amiodarone—Dizziness—Docetaxel—stomach cancer	5.74e-05	0.00036	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—stomach cancer	5.73e-05	0.000359	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—stomach cancer	5.72e-05	0.000358	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—stomach cancer	5.69e-05	0.000357	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—stomach cancer	5.66e-05	0.000355	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—stomach cancer	5.66e-05	0.000355	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—stomach cancer	5.63e-05	0.000353	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—stomach cancer	5.62e-05	0.000352	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—stomach cancer	5.59e-05	0.00035	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—stomach cancer	5.58e-05	0.00035	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—stomach cancer	5.58e-05	0.00035	CcSEcCtD
Amiodarone—Dizziness—Capecitabine—stomach cancer	5.56e-05	0.000348	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—stomach cancer	5.53e-05	0.000346	CcSEcCtD
Amiodarone—Vomiting—Docetaxel—stomach cancer	5.52e-05	0.000346	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—stomach cancer	5.51e-05	0.000345	CcSEcCtD
Amiodarone—Rash—Docetaxel—stomach cancer	5.48e-05	0.000343	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—stomach cancer	5.47e-05	0.000343	CcSEcCtD
Amiodarone—Dermatitis—Docetaxel—stomach cancer	5.47e-05	0.000343	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—stomach cancer	5.46e-05	0.000342	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—stomach cancer	5.44e-05	0.000341	CcSEcCtD
Amiodarone—Headache—Docetaxel—stomach cancer	5.44e-05	0.000341	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—stomach cancer	5.42e-05	0.00034	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—stomach cancer	5.42e-05	0.00034	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—stomach cancer	5.4e-05	0.000339	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—stomach cancer	5.4e-05	0.000338	CcSEcCtD
Amiodarone—Infection—Doxorubicin—stomach cancer	5.38e-05	0.000337	CcSEcCtD
Amiodarone—Pain—Methotrexate—stomach cancer	5.35e-05	0.000335	CcSEcCtD
Amiodarone—Vomiting—Capecitabine—stomach cancer	5.35e-05	0.000335	CcSEcCtD
Amiodarone—Shock—Doxorubicin—stomach cancer	5.33e-05	0.000334	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—stomach cancer	5.31e-05	0.000333	CcSEcCtD
Amiodarone—Rash—Capecitabine—stomach cancer	5.3e-05	0.000332	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—stomach cancer	5.3e-05	0.000332	CcSEcCtD
Amiodarone—Dermatitis—Capecitabine—stomach cancer	5.3e-05	0.000332	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—stomach cancer	5.29e-05	0.000331	CcSEcCtD
Amiodarone—Headache—Capecitabine—stomach cancer	5.27e-05	0.00033	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—stomach cancer	5.26e-05	0.00033	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—stomach cancer	5.26e-05	0.00033	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—stomach cancer	5.24e-05	0.000328	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—stomach cancer	5.22e-05	0.000327	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—stomach cancer	5.17e-05	0.000324	CcSEcCtD
Amiodarone—Nausea—Docetaxel—stomach cancer	5.16e-05	0.000323	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—stomach cancer	5.16e-05	0.000323	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—stomach cancer	5.16e-05	0.000323	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—stomach cancer	5.12e-05	0.000321	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—stomach cancer	5.09e-05	0.000319	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—stomach cancer	5.06e-05	0.000317	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—stomach cancer	5.06e-05	0.000317	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—stomach cancer	5.05e-05	0.000316	CcSEcCtD
Amiodarone—Pain—Epirubicin—stomach cancer	5.01e-05	0.000314	CcSEcCtD
Amiodarone—Constipation—Epirubicin—stomach cancer	5.01e-05	0.000314	CcSEcCtD
Amiodarone—Nausea—Capecitabine—stomach cancer	4.99e-05	0.000313	CcSEcCtD
Amiodarone—Urticaria—Methotrexate—stomach cancer	4.97e-05	0.000312	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—stomach cancer	4.95e-05	0.00031	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—stomach cancer	4.95e-05	0.00031	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—stomach cancer	4.9e-05	0.000307	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—stomach cancer	4.87e-05	0.000305	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—stomach cancer	4.83e-05	0.000303	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—stomach cancer	4.83e-05	0.000302	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—stomach cancer	4.79e-05	0.0003	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—stomach cancer	4.77e-05	0.000299	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—stomach cancer	4.71e-05	0.000295	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—stomach cancer	4.68e-05	0.000293	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—stomach cancer	4.67e-05	0.000293	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—stomach cancer	4.65e-05	0.000292	CcSEcCtD
Amiodarone—Pain—Doxorubicin—stomach cancer	4.63e-05	0.00029	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—stomach cancer	4.63e-05	0.00029	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—stomach cancer	4.63e-05	0.00029	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—stomach cancer	4.63e-05	0.00029	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—stomach cancer	4.61e-05	0.000289	CcSEcCtD
Amiodarone—Asthenia—Methotrexate—stomach cancer	4.49e-05	0.000281	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—stomach cancer	4.47e-05	0.00028	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—stomach cancer	4.43e-05	0.000278	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—stomach cancer	4.43e-05	0.000277	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—stomach cancer	4.32e-05	0.00027	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—stomach cancer	4.31e-05	0.00027	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—stomach cancer	4.28e-05	0.000268	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—stomach cancer	4.28e-05	0.000268	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—stomach cancer	4.28e-05	0.000268	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—stomach cancer	4.2e-05	0.000263	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—stomach cancer	4.14e-05	0.00026	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—stomach cancer	4.14e-05	0.000259	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—stomach cancer	4.01e-05	0.000251	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—stomach cancer	3.99e-05	0.00025	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—stomach cancer	3.98e-05	0.000249	CcSEcCtD
Amiodarone—Rash—Methotrexate—stomach cancer	3.95e-05	0.000247	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—stomach cancer	3.94e-05	0.000247	CcSEcCtD
Amiodarone—Headache—Methotrexate—stomach cancer	3.92e-05	0.000246	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—stomach cancer	3.89e-05	0.000244	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—stomach cancer	3.87e-05	0.000243	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—stomach cancer	3.83e-05	0.00024	CcSEcCtD
Amiodarone—Vomiting—Epirubicin—stomach cancer	3.72e-05	0.000233	CcSEcCtD
Amiodarone—Nausea—Methotrexate—stomach cancer	3.72e-05	0.000233	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—stomach cancer	3.71e-05	0.000232	CcSEcCtD
Amiodarone—Rash—Epirubicin—stomach cancer	3.69e-05	0.000231	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—stomach cancer	3.69e-05	0.000231	CcSEcCtD
Amiodarone—Headache—Epirubicin—stomach cancer	3.67e-05	0.00023	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—stomach cancer	3.58e-05	0.000225	CcSEcCtD
Amiodarone—Nausea—Epirubicin—stomach cancer	3.48e-05	0.000218	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—stomach cancer	3.45e-05	0.000216	CcSEcCtD
Amiodarone—Rash—Doxorubicin—stomach cancer	3.42e-05	0.000214	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—stomach cancer	3.41e-05	0.000214	CcSEcCtD
Amiodarone—Headache—Doxorubicin—stomach cancer	3.4e-05	0.000213	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—stomach cancer	3.22e-05	0.000202	CcSEcCtD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.77e-06	6.84e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALDH7A1—stomach cancer	5.77e-06	6.83e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PLCE1—stomach cancer	5.77e-06	6.83e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	5.74e-06	6.8e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CD44—stomach cancer	5.72e-06	6.77e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—MTHFR—stomach cancer	5.68e-06	6.72e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTT1—stomach cancer	5.63e-06	6.67e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP2A6—stomach cancer	5.57e-06	6.59e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.55e-06	6.57e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ERCC2—stomach cancer	5.53e-06	6.55e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—UMPS—stomach cancer	5.53e-06	6.54e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FYN—stomach cancer	5.51e-06	6.52e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTT1—stomach cancer	5.5e-06	6.51e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP2A6—stomach cancer	5.44e-06	6.43e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALDOB—stomach cancer	5.43e-06	6.43e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKR1C3—stomach cancer	5.42e-06	6.41e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKR1C3—stomach cancer	5.29e-06	6.26e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ENO1—stomach cancer	5.28e-06	6.25e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.27e-06	6.23e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CD44—stomach cancer	5.25e-06	6.21e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CAV1—stomach cancer	5.23e-06	6.2e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—APOA1—stomach cancer	5.22e-06	6.18e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	5.21e-06	6.17e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—MTHFR—stomach cancer	5.2e-06	6.16e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.19e-06	6.15e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTT1—stomach cancer	5.18e-06	6.13e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGFR2—stomach cancer	5.17e-06	6.12e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ENO1—stomach cancer	5.15e-06	6.1e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPP2R1A—stomach cancer	5.15e-06	6.1e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PDHA1—stomach cancer	5.14e-06	6.08e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ECHS1—stomach cancer	5.14e-06	6.08e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTT1—stomach cancer	5.14e-06	6.08e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP2A6—stomach cancer	5.12e-06	6.06e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.12e-06	6.06e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.11e-06	6.05e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.09e-06	6.03e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP2A6—stomach cancer	5.08e-06	6.01e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTP1—stomach cancer	5.05e-06	5.98e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALOX5—stomach cancer	5.05e-06	5.97e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKR1C3—stomach cancer	4.98e-06	5.9e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—HMOX1—stomach cancer	4.98e-06	5.9e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—DPYD—stomach cancer	4.96e-06	5.88e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKR1C3—stomach cancer	4.94e-06	5.85e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPP2R1A—stomach cancer	4.86e-06	5.76e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ENO1—stomach cancer	4.86e-06	5.75e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—FADS1—stomach cancer	4.83e-06	5.72e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMP—stomach cancer	4.83e-06	5.72e-05	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	4.82e-06	5.7e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ENO1—stomach cancer	4.81e-06	5.7e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CAV1—stomach cancer	4.8e-06	5.68e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—APOA1—stomach cancer	4.79e-06	5.67e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTP1—stomach cancer	4.77e-06	5.65e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IRS2—stomach cancer	4.74e-06	5.61e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.73e-06	5.61e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—HMOX1—stomach cancer	4.71e-06	5.57e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TYMS—stomach cancer	4.7e-06	5.56e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CD44—stomach cancer	4.68e-06	5.54e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTM1—stomach cancer	4.64e-06	5.5e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PPARG—stomach cancer	4.6e-06	5.45e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CAV1—stomach cancer	4.59e-06	5.44e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APOA1—stomach cancer	4.58e-06	5.42e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CD44—stomach cancer	4.57e-06	5.41e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.54e-06	5.38e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SREBF2—stomach cancer	4.52e-06	5.36e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.5e-06	5.33e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—RORA—stomach cancer	4.47e-06	5.29e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPP2R1A—stomach cancer	4.46e-06	5.28e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TYMS—stomach cancer	4.44e-06	5.25e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTT1—stomach cancer	4.39e-06	5.2e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTM1—stomach cancer	4.39e-06	5.19e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTP1—stomach cancer	4.38e-06	5.18e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PRKCB—stomach cancer	4.37e-06	5.18e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ERCC2—stomach cancer	4.36e-06	5.17e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6ST—stomach cancer	4.35e-06	5.15e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP2A6—stomach cancer	4.34e-06	5.14e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—HMOX1—stomach cancer	4.31e-06	5.11e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CD44—stomach cancer	4.31e-06	5.1e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CD44—stomach cancer	4.27e-06	5.05e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKR1C3—stomach cancer	4.22e-06	5e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PPARG—stomach cancer	4.22e-06	4.99e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALDOB—stomach cancer	4.19e-06	4.96e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APC—stomach cancer	4.18e-06	4.95e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.14e-06	4.9e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ALB—stomach cancer	4.14e-06	4.9e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ERCC2—stomach cancer	4.12e-06	4.88e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ENO1—stomach cancer	4.11e-06	4.87e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—MTHFR—stomach cancer	4.1e-06	4.86e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TYMS—stomach cancer	4.07e-06	4.82e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.05e-06	4.79e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTM1—stomach cancer	4.02e-06	4.76e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	4.01e-06	4.74e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPP2R1A—stomach cancer	3.98e-06	4.71e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—NOS3—stomach cancer	3.96e-06	4.69e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTP1—stomach cancer	3.91e-06	4.62e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALOX5—stomach cancer	3.89e-06	4.61e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPP2R1A—stomach cancer	3.89e-06	4.6e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6R—stomach cancer	3.88e-06	4.6e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—MTHFR—stomach cancer	3.88e-06	4.59e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—HMOX1—stomach cancer	3.85e-06	4.56e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—DPYD—stomach cancer	3.83e-06	4.54e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	3.81e-06	4.51e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTP1—stomach cancer	3.81e-06	4.51e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—stomach cancer	3.81e-06	4.51e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ALB—stomach cancer	3.79e-06	4.49e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CAV1—stomach cancer	3.78e-06	4.48e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ERCC2—stomach cancer	3.78e-06	4.47e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—APOA1—stomach cancer	3.78e-06	4.47e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—HMOX1—stomach cancer	3.76e-06	4.45e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPP2R1A—stomach cancer	3.66e-06	4.33e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CD44—stomach cancer	3.65e-06	4.32e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	3.64e-06	4.31e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	3.64e-06	4.31e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TYMS—stomach cancer	3.63e-06	4.3e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPP2R1A—stomach cancer	3.63e-06	4.3e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NOS3—stomach cancer	3.63e-06	4.29e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—stomach cancer	3.62e-06	4.29e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—stomach cancer	3.6e-06	4.26e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—stomach cancer	3.59e-06	4.25e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTM1—stomach cancer	3.59e-06	4.25e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CAV1—stomach cancer	3.57e-06	4.23e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—APOA1—stomach cancer	3.57e-06	4.22e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—stomach cancer	3.56e-06	4.22e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—MTHFR—stomach cancer	3.55e-06	4.21e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TYMS—stomach cancer	3.54e-06	4.19e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—HMOX1—stomach cancer	3.54e-06	4.19e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.54e-06	4.19e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—HMOX1—stomach cancer	3.51e-06	4.16e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RHOA—stomach cancer	3.51e-06	4.15e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTM1—stomach cancer	3.5e-06	4.15e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NOS3—stomach cancer	3.47e-06	4.11e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.42e-06	4.04e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTT1—stomach cancer	3.39e-06	4.01e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ERCC2—stomach cancer	3.37e-06	3.99e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.35e-06	3.96e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TYMS—stomach cancer	3.34e-06	3.95e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPARG—stomach cancer	3.33e-06	3.94e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—stomach cancer	3.32e-06	3.93e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TYMS—stomach cancer	3.31e-06	3.92e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	3.31e-06	3.92e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTM1—stomach cancer	3.3e-06	3.91e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ERCC2—stomach cancer	3.29e-06	3.9e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CAV1—stomach cancer	3.28e-06	3.88e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTM1—stomach cancer	3.27e-06	3.87e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—APOA1—stomach cancer	3.27e-06	3.87e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.26e-06	3.86e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—stomach cancer	3.25e-06	3.85e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ENO1—stomach cancer	3.17e-06	3.76e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—MTHFR—stomach cancer	3.17e-06	3.75e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPARG—stomach cancer	3.14e-06	3.72e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.13e-06	3.71e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ERCC2—stomach cancer	3.1e-06	3.67e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.1e-06	3.67e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—MTHFR—stomach cancer	3.1e-06	3.66e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—stomach cancer	3.08e-06	3.65e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ERCC2—stomach cancer	3.08e-06	3.64e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—stomach cancer	3.06e-06	3.62e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—stomach cancer	3.04e-06	3.6e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	3.01e-06	3.56e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HMOX1—stomach cancer	3e-06	3.55e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALB—stomach cancer	2.99e-06	3.54e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—stomach cancer	2.93e-06	3.47e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CAV1—stomach cancer	2.93e-06	3.46e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APOA1—stomach cancer	2.92e-06	3.46e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—MTHFR—stomach cancer	2.92e-06	3.45e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—MTHFR—stomach cancer	2.89e-06	3.42e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARG—stomach cancer	2.88e-06	3.41e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—stomach cancer	2.87e-06	3.4e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—JUN—stomach cancer	2.86e-06	3.39e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NOS3—stomach cancer	2.86e-06	3.39e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CAV1—stomach cancer	2.86e-06	3.38e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APOA1—stomach cancer	2.85e-06	3.37e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TYMS—stomach cancer	2.83e-06	3.35e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALB—stomach cancer	2.83e-06	3.35e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CD44—stomach cancer	2.82e-06	3.33e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTM1—stomach cancer	2.8e-06	3.31e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.79e-06	3.31e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—stomach cancer	2.79e-06	3.3e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	2.78e-06	3.29e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK8—stomach cancer	2.71e-06	3.21e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NOS3—stomach cancer	2.7e-06	3.2e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CAV1—stomach cancer	2.69e-06	3.19e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APOA1—stomach cancer	2.68e-06	3.18e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CAV1—stomach cancer	2.67e-06	3.16e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APOA1—stomach cancer	2.66e-06	3.15e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ERCC2—stomach cancer	2.63e-06	3.11e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—stomach cancer	2.62e-06	3.1e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALB—stomach cancer	2.59e-06	3.07e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARG—stomach cancer	2.57e-06	3.04e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.55e-06	3.02e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARG—stomach cancer	2.51e-06	2.97e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—stomach cancer	2.5e-06	2.96e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NOS3—stomach cancer	2.48e-06	2.93e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—stomach cancer	2.48e-06	2.93e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—stomach cancer	2.47e-06	2.93e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—MTHFR—stomach cancer	2.47e-06	2.93e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.39e-06	2.83e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK3—stomach cancer	2.37e-06	2.8e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARG—stomach cancer	2.37e-06	2.8e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—stomach cancer	2.35e-06	2.78e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARG—stomach cancer	2.34e-06	2.78e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HMOX1—stomach cancer	2.32e-06	2.74e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALB—stomach cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—stomach cancer	2.3e-06	2.73e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CAV1—stomach cancer	2.28e-06	2.7e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APOA1—stomach cancer	2.27e-06	2.69e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—stomach cancer	2.27e-06	2.68e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALB—stomach cancer	2.26e-06	2.67e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK1—stomach cancer	2.25e-06	2.67e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—stomach cancer	2.25e-06	2.67e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—stomach cancer	2.23e-06	2.64e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NOS3—stomach cancer	2.21e-06	2.62e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMS—stomach cancer	2.18e-06	2.58e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.18e-06	2.58e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NOS3—stomach cancer	2.16e-06	2.56e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTM1—stomach cancer	2.16e-06	2.55e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—stomach cancer	2.13e-06	2.52e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALB—stomach cancer	2.13e-06	2.52e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALB—stomach cancer	2.11e-06	2.5e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—stomach cancer	2.04e-06	2.42e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NOS3—stomach cancer	2.03e-06	2.41e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ERCC2—stomach cancer	2.03e-06	2.4e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—stomach cancer	2.02e-06	2.4e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NOS3—stomach cancer	2.02e-06	2.39e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARG—stomach cancer	2e-06	2.37e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—stomach cancer	1.97e-06	2.34e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	1.95e-06	2.31e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MTHFR—stomach cancer	1.91e-06	2.26e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—stomach cancer	1.89e-06	2.24e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—stomach cancer	1.86e-06	2.2e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—stomach cancer	1.84e-06	2.18e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—stomach cancer	1.81e-06	2.14e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALB—stomach cancer	1.8e-06	2.13e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CAV1—stomach cancer	1.76e-06	2.08e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APOA1—stomach cancer	1.76e-06	2.08e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—stomach cancer	1.73e-06	2.05e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NOS3—stomach cancer	1.72e-06	2.04e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—stomach cancer	1.61e-06	1.91e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—stomach cancer	1.58e-06	1.87e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARG—stomach cancer	1.55e-06	1.83e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—stomach cancer	1.52e-06	1.8e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALB—stomach cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NOS3—stomach cancer	1.33e-06	1.57e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.24e-06	1.47e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—stomach cancer	1.22e-06	1.44e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—stomach cancer	1.21e-06	1.44e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.14e-06	1.36e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.13e-06	1.34e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—stomach cancer	9.7e-07	1.15e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—stomach cancer	7.48e-07	8.86e-06	CbGpPWpGaD
